Clinical Trial

A Study of HDM2012 in Patients With Advanced Solid Tumor

Name: A Study of HDM2012 in Patients With Advanced Solid Tumor — clinical trial record (NCT07100249)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a first-in-human (FIH) study to evaluate the safety and preliminary efficacy of experimental drug HDM2012 in patients with advanced solid tumors.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-07-27; most recent amendment 2025-08-06.

Trial Details

NCT Number	NCT07100249
Lead Sponsor	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	129 participants
Start Date	2025-08-06
Primary Completion	2027-10 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2025-08-08